MAPT and Alzheimer disease: A recent study using a sensitive, selective, and unbiased liquid-chromatography tandem mass spectrometry (LC-MS/MS) method was used to analyse AD and control brain samples and unravelled an association between aggregated tau PTMs and Braak stages, suggesting a potential impact of specific PTMs on AD progression19.